| # | Drug | Count |
|---|---|---|
| 0 | OLANZAPINE | 29 |
| 1 | RISPERIDONE | 27 |
| 2 | CLOZAPINE | 26 |
| 3 | HALOPERIDOL LACTATE | 24 |
| 4 | HALOPERIDOL | 22 |
| 5 | LORAZEPAM | 22 |
| 6 | QUETIAPINE | 19 |
| 7 | ARIPIPRAZOLE | 16 |
| 8 | ARIPIPRAZOLE ORAL | 13 |
| 9 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IMIPRAMINE HYDROCHLORIDE | 2 | 0.0035 |
| 1 | AMISULPRIDE | 11 | 0.0018 |
| 2 | SORBITOL | 1 | 0.0017 |
| 3 | CEFPROZIL | 1 | 0.0013 |
| 4 | HALOPERIDOL LACTATE | 24 | 0.0010 |
| 5 | CLEAR MINT, GEL TOOTHPASTE | 1 | 0.0009 |
| 6 | SODIUM FLUORIDE F18 | 1 | 0.0009 |
| 7 | SODIUM FLUORIDE F-18 | 1 | 0.0009 |
| 8 | MIGLUSTAT | 1 | 0.0009 |
| 9 | CHLORPROMAZINE | 5 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 75 |
| 1 | Benzodiazepine [EPC] | 44 |
| 2 | Typical Antipsychotic [EPC] | 22 |
| 3 | Corticosteroid [EPC] | 13 |
| 4 | Dopamine-2 Receptor Antagonist [EPC] | 12 |
| 5 | Mood Stabilizer [EPC] | 12 |
| 6 | Anti-epileptic Agent [EPC] | 11 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 8 | General Anesthetic [EPC] | 6 |
| 9 | Opioid Agonist [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 12 | 0.0015 |
| 1 | Typical Antipsychotic [EPC] | 22 | 0.0009 |
| 2 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 3 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 4 | Catechol-O-Methyltransferase Inhibitor [EPC] | 2 | 0.0004 |
| 5 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 6 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Sigma-1 Agonist [EPC] | 2 | 0.0002 |
| 8 | Atypical Antipsychotic [EPC] | 75 | 0.0002 |
| 9 | Orexin Receptor Antagonist [EPC] | 3 | 0.0002 |